References

From traditional ethnopharmacology to modern natural drug discovery: a methodology discussion and specific examples

10.3390/molecules27134060 · 2022 · External reference

Medical ethnobotany

10.1186/s12906-024-04515-0 · 2024 · External reference

The Ethnopharmacologic Contribution to Bioprospecting Natural Products

10.1146/annurev-pharmtox-010617-052703 · 2018 · External reference

Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems

10.1016/j.biopha.2023.116039 · 2024 · External reference

Natural products derived from traditional Chinese medicines targeting ER stress for the treatment of kidney diseases

10.1080/0886022x.2024.2396446 · 2024 · External reference

The anti-inflammatory properties of green tea extract protect against gentamicin-induced kidney injury

10.1016/j.biopha.2024.117267 · 2024 · External reference

A review of the role of green tea (Camellia sinensis) in antiphotoaging, stress resistance, neuroprotection, and autophagy

10.3390/nu11020474 · 2019 · External reference

Molecular interactions between reactive oxygen species and autophagy in kidney disease

10.3390/ijms20153791 · 2019 · External reference

Oxidant mechanisms in renal injury and disease

10.1089/ars.2016.6665 · 2016 · External reference

Mitochondrial dysfunction in the pathophysiology of renal diseases

10.1152/ajprenal.00571.2013 · 2014 · External reference

Potential therapeutic effects of natural plant compounds in kidney disease

10.3390/molecules26206096 · 2021 · External reference

Liver injury from herbal and dietary supplements

10.1002/hep.28813 · 2017 · External reference

United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts

10.1016/j.toxrep.2020.02.008 · 2020 · External reference

Hepatotoxicity of green tea: an update

10.1007/s00204-015-1521-x · 2015 · External reference

The safety of green tea and green tea extract consumption in adults – Results of a systematic review

10.1016/j.yrtph.2018.03.019 · 2018 · External reference

Molecular mechanisms of epigallocatechin-3-gallate for prevention of chronic kidney disease and renal fibrosis: preclinical evidence

10.1093/cdn/nzz101 · 2019 · External reference

Green tea (Camellia sinensis): a review of its phytochemistry, pharmacology, and toxicology

10.3390/molecules27123909 · 2022 · External reference

Tea polyphenols in promotion of human health

10.3390/nu11010039 · 2018 · External reference

Optimizing catechin extraction from green tea waste: comparative analysis of hot water, ultrasound-assisted, and ethanol methods for enhanced antioxidant recovery

10.1002/fsn3.4161 · 2024 · External reference

Galloylation of polyphenols alters their biological activity

10.1016/j.fct.2017.04.021 · 2017 · External reference

The galloyl group enhances the inhibitory activity of catechins against LPS-Triggered Inflammation in RAW264.7 cells

10.3390/foods13162616 · 2024 · External reference

Tea-break with epigallocatechin gallate derivatives – Powerful polyphenols of great potential for medicine

10.1016/j.ejmech.2023.115820 · 2023 · External reference

Scientific opinion on the safety of green tea catechins

2018 · External reference

Green tea (Camellia sinensis): a review of its phytochemistry, pharmacology, and toxicology

10.3390/molecules27123909 · 2022 · External reference

The role of catechins in cellular responses to oxidative stress

10.3390/molecules23040965 · 2018 · External reference

NF-κB in biology and targeted therapy: new insights and translational implications

10.1038/s41392-024-01757-9 · 2024 · External reference

Anti-inflammatory action of green tea

10.2174/1871523015666160915154443 · 2016 · External reference

Reactive oxygen species and redox signaling in chronic kidney disease

10.3390/cells9061342 · 2020 · External reference

Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation

10.1111/bcpt.12383 · 2015 · External reference

Protective effects of epigallocatechin-3-gallate from green tea in various kidney diseases

10.1093/advances/nmy077 · 2019 · External reference

Oxidative stress and endoplasmic stress in calcium oxalate stone disease: the chicken or the egg?

10.1080/10715762.2020.1751835 · 2020 · External reference

Degraded Porphyra yezoensis polysaccharide protects HK-2 cells and reduces nano-COM crystal toxicity, adhesion, and endocytosis

10.1039/d0tb00360c · 2020 · External reference

Modulation of rat kidney stone crystallization and the relative oxidative stress pathway by green tea polyphenol

10.1021/acsomega.0c05903 · 2021 · External reference

Fluid intake and dietary factors and the risk of incident kidney stones in UK biobank: a population-based prospective cohort study

10.1016/j.euf.2019.05.002 · 2020 · External reference

Tea and coffee consumption and the risk of urinary stones: a systematic review of the epidemiological data

10.1007/s00345-020-03561-w · 2020 · External reference

Consumption of tea, alcohol, and fruits and risk of kidney stones: A prospective cohort study in 0.5 million Chinese adults

10.3390/nu13041119 · 2021 · External reference

Nutrition and kidney stone disease

10.3390/nu13061917 · 2021 · External reference

Effects and mechanisms of tea for the prevention and management of diabetes mellitus and diabetic complications: an updated review

10.3390/antiox8060170 · 2019 · External reference

(+)-Catechin ameliorates diabetic nephropathy injury by inhibiting endoplasmic reticulum stress-related NLRP3-mediated inflammation

10.1039/d3fo05400d · 2024 · External reference

Green tea peptides ameliorate diabetic nephropathy by inhibiting the TGF-β/Smad signaling pathway in mice

10.1039/d1fo03615g · 2022 · External reference

The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial

10.1038/srep28282 · 2016 · External reference

The mechanisms of ameliorating effect of a green tea polyphenol on diabetic nephropathy based on diacylglycerol kinase α

10.1038/s41598-020-68716-6 · 2020 · External reference

Green tea extract increases soluble RAGE and improves renal function in patients with diabetic nephropathy

10.1089/jmf.2020.0212 · 2021 · External reference

Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

10.1016/j.kint.2020.04.020 · 2020 · External reference

The mechanism of drug nephrotoxicity and the methods for preventing kidney damage

10.3390/ijms22116109 · 2021 · External reference

Natural products: potential treatments for cisplatin-induced nephrotoxicity

10.1038/s41401-021-00620-9 · 2021 · External reference

Preventing contrast-induced nephropathy (CIN) with herbal medicines: a review

10.1002/ptr.6880 · 2020 · External reference

Rhabdomyolysis-induced acute kidney injury and concomitant apoptosis induction via ROS-mediated ER stress is efficaciously counteracted by epigallocatechin gallate

10.1016/j.jnutbio.2022.109134 · 2022 · External reference

Polyphenol (-)-Epigallocatechin Gallate (EGCG) mitigated kidney injury by regulating metabolic homeostasis and mitochondrial dynamics involvement with Drp1-mediated mitochondrial fission in mice

10.1016/j.fct.2024.114906 · 2024 · External reference

Catechins: therapeutic perspectives in COVID-19-associated acute kidney injury

10.3390/molecules26195951 · 2021 · External reference

Comparative study of the anti-inflammatory activity of etoricoxib and Matcha green tea against acute kidney injury induced by gamma radiation in rats

10.1080/09553002.2024.2338515 · 2024 · External reference

Epigallocatechin-3-gallate in combination with corticosteroids mitigates heat stress-induced acute kidney injury through modulating heat shock protein 70 and toll-like receptor 4-dependent pathways

10.1002/ptr.7834 · 2023 · External reference

Epigallocatechin gallate attenuates gentamicin-induced nephrotoxicity by suppressing apoptosis and ferroptosis

10.3390/molecules27238564 · 2022 · External reference

An overview on the potential roles of EGCG in the treatment of COVID-19 infection

10.2147/dddt.s314666 · 2021 · External reference

Antiviral Effects of Green Tea EGCG and Its Potential Application against COVID-19

10.3390/molecules26133962 · 2021 · External reference

The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety

10.3389/fphar.2013.00177 · 2014 · External reference

Dapagliflozin in Patients with Chronic Kidney Disease

10.1056/nejmoa2024816 · 2020 · External reference

Empagliflozin in patients with chronic kidney disease

10.1056/nejmoa2204233 · 2023 · External reference

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

10.1056/nejmoa2025845 · 2020 · External reference

Liraglutide and Renal Outcomes in Type 2 Diabetes

10.1056/nejmoa1616011 · 2017 · External reference

Effects of semaglutide on chronic kidney disease in patients with Type 2 Diabetes

10.1056/nejmoa2403347 · 2024 · External reference

Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease

10.1016/j.kint.2023.10.018 · 2024 · External reference

A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases

10.1016/j.kint.2019.07.012 · 2019 · External reference